{"title":"干扰素治疗骨巨细胞瘤","authors":"A. Yasko","doi":"10.1097/BCO.0B013E328010913B","DOIUrl":null,"url":null,"abstract":"Purpose of reviewInhibition of key regulators of angiogenesis has gained momentum as a promising approach for the treatment of vascular tumors. Antitumor activity of interferons has been observed in childhood hemangiomas, hematologic malignancies and giant cell lesions of the mandible. The response","PeriodicalId":81061,"journal":{"name":"Current opinion in orthopaedics","volume":"17 1","pages":"568-572"},"PeriodicalIF":0.0000,"publicationDate":"2006-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/BCO.0B013E328010913B","citationCount":"12","resultStr":"{\"title\":\"Interferon therapy for giant cell tumor of bone\",\"authors\":\"A. Yasko\",\"doi\":\"10.1097/BCO.0B013E328010913B\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Purpose of reviewInhibition of key regulators of angiogenesis has gained momentum as a promising approach for the treatment of vascular tumors. Antitumor activity of interferons has been observed in childhood hemangiomas, hematologic malignancies and giant cell lesions of the mandible. The response\",\"PeriodicalId\":81061,\"journal\":{\"name\":\"Current opinion in orthopaedics\",\"volume\":\"17 1\",\"pages\":\"568-572\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2006-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1097/BCO.0B013E328010913B\",\"citationCount\":\"12\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current opinion in orthopaedics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/BCO.0B013E328010913B\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current opinion in orthopaedics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/BCO.0B013E328010913B","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Purpose of reviewInhibition of key regulators of angiogenesis has gained momentum as a promising approach for the treatment of vascular tumors. Antitumor activity of interferons has been observed in childhood hemangiomas, hematologic malignancies and giant cell lesions of the mandible. The response